MANCHESTER-based Premaitha Health, the developer of a ground-breaking non-invasive prenatal test (NIPT) for Down’s Syndrome, has appointed Adgenix as its exclusive distributor in France.
Dr Stephen Little, chief executive of Premaitha said: “Securing our first French partnership with LaboSud and Adgenix is an important step forward for us as we continue to expand the reach of the IONA test across Europe. Our NIPT test provides more accurate and faster results that will benefit more pregnant women in France.
“We look forward to getting the IONA test up and running at LaboSud with our world class technical support team and training programme. The support of Adgenix as our local distributor has also been a huge benefit in establishing this customer and we hope to continue to develop this and other relationships.”
See article in full at BusinessDesk.com